Xenitra (ASX:XEN)
ASX announcement history & article coverage
Transparent by design.
Announcments by Xenitra (ASX:XEN) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 4G and Corporate Governance Statement
Appendix 4E and Annual Report
Xenitra Limited reports strategic turnaround with revenue recovery, cost cuts, and new growth platforms; loss widens to $5.18 million
Proposed issue of securities - XEN
Xenitra Raises $1.5m to Accelerate High-Margin Sales Growth
Xenitra raises A$1.5 million placement to accelerate higher-margin sales growth across OTC, FSMP, and OPAL
Trading Halt
$5m Offtake Agreement Expands OTC-Medicine Business
Xenitra signs A$5 million three-year FSMP procurement agreement with Joy Charm
Investor Presentation
Quarterly Activities/Appendix 4C Cash Flow Report
Xenitra reports positive cash flow turnaround and strong growth in OTC and OPAL sales
Investor Webinar
$12M OFFTAKE AGREEMENT WITH LEADING OTC-PHARMACEUTICAL
Xenitra secures A$12 million OTC pharmaceutical procurement deal with Kangsheng in China
Xenitra Investor Webinar
$1.1m in OPAL-Tokenised Product Sales in First 7 Weeks
Xenitra's OPAL Tokenised Product Sales Surpass $1.1M with 400+ Partners in 7 Weeks
XEN Appointed as Exclusive Biomiq Skincare China Distributor
Xenitra secures exclusive 4-year China distribution deal for Biomiq Skincare with $5m minimum sales target